K. Yamamura

发表

Ocular Membrane Permeability of Hydrophilic Drugs for Ocular Peptide Delivery

H. Sasaki, K. Nishida, J. Nakamura, 1997, The Journal of pharmacy and pharmacology.

Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes

S. Kawakami, H. Sasaki, M. Nakashima, 2001, The Journal of pharmacy and pharmacology.

Delivery of drugs to the eye by topical application

H. Sasaki, K. Nishida, J. Nakamura, 1996, Progress in Retinal and Eye Research.

Ophthalmic Preservatives as Absorption Promoters for Ocular Drug Delivery

H. Sasaki, K. Nishida, J. Nakamura, 1995, The Journal of pharmacy and pharmacology.

Effect of Preservatives on Systemic Delivery of Insulin by Ocular Instillation in Rabbits

H. Sasaki, K. Nishida, J. Nakamura, 1994, The Journal of pharmacy and pharmacology.

Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)

M. Aihara, Naveed B K Shams, Fenghe Lu, 2019, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent.

Naveed B K Shams, Noriko Odani-Kawabata, K. Yamamura, 2018, Investigative ophthalmology & visual science.

Glaucoma Pharmacologic Characterization of Omidenepag Isopropyl , a Novel Selective EP 2 Receptor Agonist , as an Ocular Hypotensive Agent

Naveed B K Shams, Noriko Odani-Kawabata, K. Yamamura, 2018 .

In situ ocular absorption of tilisolol through ocular membranes in albino rabbits.

S. Kawakami, H. Sasaki, K. Nishida, 1996, Journal of pharmaceutical sciences.

Ocular absorption behavior of palmitoyl tilisolol, an amphiphilic prodrug of tilisolol, for ocular drug delivery.

S. Kawakami, H. Sasaki, K. Kobayashi, 2001, Journal of pharmaceutical sciences.

Characterization of ocular pharmacokinetics of tilisolol after instillation into anesthetized rabbits.

H. Sasaki, M. Nakashima, K. Nishida, 1999, Biological & pharmaceutical bulletin.

In‐situ Ocular Absorption of Ophthalmic β‐Blockers through Ocular Membranes in Albino Rabbits

H. Sasaki, K. Nishida, J. Nakamura, 1997, The Journal of pharmacy and pharmacology.

Enhancement of ocular drug penetration.

H. Sasaki, M. Nakashima, K. Nishida, 1999, Critical reviews in therapeutic drug carrier systems.

Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugs.

S. Kawakami, H. Sasaki, M. Nakashima, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Penetration of β‐Blockers through Ocular Membranes in A1bino Rabbits

H. Sasaki, K. Nishida, J. Nakamura, 1995 .

Modification of ocular permeability of peptide drugs by absorption promoters.

H. Sasaki, M. Nakashima, K. Nishida, 2000, Biological & pharmaceutical bulletin.

In Vivo Ocular Pharmacokinetic Model for Designing Dosage Schedules and Formulations of Ophthalmic Drugs in Human

H. Sasaki, M. Nakashima, K. Nishida, 1997 .

Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug.

H. Sasaki, K. Nishida, J. Nakamura, 1995, Journal of drug targeting.

Characterization of Ocular Pharmacokinetics of Beta-Blockers Using a Diffusion Model After Instillation

H. Sasaki, M. Nakashima, K. Nishida, 1999, Pharmaceutical Research.

Pharmacokinetics, Safety and IOP Lowering Profiles of omidenepag isopropyl, a Selective EP2 Agonist in Healthy Japanese and Caucasian Volunteers (Phase I Study)

M. Aihara, Naveed B K Shams, Fenghe Lu, 2017 .

Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle.

H. Sasaki, M. Nakashima, K. Nishida, 2000, Biological and Pharmaceutical Bulletin.